3-20040509-GCTGCGGGGCAGGAGCCGGGGCAGGGGCCGGGCCCGGGGCGCTGCCCCCGCAGCCTGCGGCGCTTCCGCCCGCGCCCCCGCAGGGCTCCCCCTGCGCCGCTGCCGCCGGGGGCTCGGGCGC-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_003884.5(KAT2B):c.39_158del(p.Ala14_Gly53del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00111 in 1,031,618 control chromosomes in the GnomAD database, including 42 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00022 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 41 hom. )
Consequence
KAT2B
NM_003884.5 disruptive_inframe_deletion
NM_003884.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.67
Genes affected
KAT2B (HGNC:8638): (lysine acetyltransferase 2B) CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 3-20040509-GCTGCGGGGCAGGAGCCGGGGCAGGGGCCGGGCCCGGGGCGCTGCCCCCGCAGCCTGCGGCGCTTCCGCCCGCGCCCCCGCAGGGCTCCCCCTGCGCCGCTGCCGCCGGGGGCTCGGGCGC-G is Benign according to our data. Variant chr3-20040509-GCTGCGGGGCAGGAGCCGGGGCAGGGGCCGGGCCCGGGGCGCTGCCCCCGCAGCCTGCGGCGCTTCCGCCCGCGCCCCCGCAGGGCTCCCCCTGCGCCGCTGCCGCCGGGGGCTCGGGCGC-G is described in ClinVar as [Likely_benign]. Clinvar id is 3044350.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 33 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT2B | NM_003884.5 | c.39_158del | p.Ala14_Gly53del | disruptive_inframe_deletion | 1/18 | ENST00000263754.5 | NP_003875.3 | |
KAT2B | XM_005265528.5 | c.39_158del | p.Ala14_Gly53del | disruptive_inframe_deletion | 1/17 | XP_005265585.1 | ||
KAT2B | XM_047449147.1 | c.-457_-338del | 5_prime_UTR_variant | 1/20 | XP_047305103.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000225 AC: 33AN: 146972Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
33
AN:
146972
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00126 AC: 1111AN: 884546Hom.: 41 AF XY: 0.00129 AC XY: 533AN XY: 412902
GnomAD4 exome
AF:
AC:
1111
AN:
884546
Hom.:
AF XY:
AC XY:
533
AN XY:
412902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 33AN: 147072Hom.: 1 Cov.: 31 AF XY: 0.000168 AC XY: 12AN XY: 71620
GnomAD4 genome
AF:
AC:
33
AN:
147072
Hom.:
Cov.:
31
AF XY:
AC XY:
12
AN XY:
71620
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KAT2B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 19, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at